CategoriesView All (621)
Models Female (32,695)
Models Male (2,277)
People Walls: 247,386
All Wallpapers: 1,696,349
Tag Count: 9,948,936
5,170 Users Online55 members, 5,115 guests
abydorisles, allgovernmentjobs, alu1mni, aurlshortner, balancedcomfort, bedite, BestShoesDisney, biyone6769, byoviral, Cruella747, CustomRugs31, daftarslot2, davrux, deorquidea, DonMFrost, educationrefer, elsieespinoza99, Heritage343, Homeelevators, hthai88a4, ia_ahmad20, ikcinbots, katinovphoto, Lamamake, livedrawtaiwan, lootwow711315, manohat, mdaughters21, MeadElectric, MiaBella, nancyjustin1, nhacai789betvc, nhacaiqh88top, nhacaiw88org, nohu-dev, nouramrfouad94, Obnox, onlyfan677, plasticinj, pq88win, pramod12345, ProjectFlowcouk, roofTtech24, rubi1, sakeleo213, sm66azcom, tekirdagagirnakliyat, thanh62, theestateplanfl, thejden, thelentorhillresidenc..., TruSecAi_Ramnk, voodooforlove506, vrnonaircndtining, wmerchdetlo
Most users ever online was 150,759 on 9/11/14.
COVID 19 PANDEMIC WAS CREATED TO BRING YOU DOWN AND TO CLEANSE THE WORLD FROM POOR WHO ARE SEEN BY ELITES AS DEAD-WEIGHTS TO THEM
THAT'S WHY THEY STOPPED MEDS LIKE HYDROXYCHLOROQUINE FROM BEING USED ON PATIENTS WHO WERE DYING FROM THROMBOLYTIC COMPLICATIONS IN LUNGS, BRAIN, HEART AND KIDNEYS
"An increasing number of evidence have reported the association of COVID-19 with increased incidence of thrombotic events. High incidences were initially reported in critically ill COVID-19 patients, but subsequently an increased incidence was also noticed in non-critically ill general ward patients. This has led to a universal recommendation of thromboprophylaxis for all COVID-19 patients by ASH and ISTH. As the data on COVID-19 and thrombosis continue to develop and evolve, we examined the data in two aspects. Firstly, other non-SARS-CoV-2 viral respiratory infections have also been reported to be associated with thrombotic events, be it arterial or venous. Thus, we aimed to compare the thrombotic rates between these two groups of patients directly to hopefully ascertain the actual thrombotic tendency in COVID-19 infections. Secondly, global hemostatic assays such as thromboelastogram and clot waveform analysis (CWA) have been used to demonstrate hypercoagulability in COVID-19 patients, albeit in a small group of patients and only in the critically ill. Incorporating these laboratory results into the management of thromboprophylaxis in COVID-19 is an attractive notion but more data and studies are definitely needed. Here, we evaluate the dynamic changes of hemostatic assays in patients with COVID-19 to better understand the overall coagulation profiles of COVID-19 infection."